Welcome to D2 Dermatology and D2 Derma Europe!

D2 Dermatology Ltd. and its European subsidiary D2 Derma Europe Ltd. are life science companies which focus on new concepts and drugs for the treatment of complex skin diseases.

They are evaluating drugs derived from natural sources for topical applications where efficacy and safety are validated in clinical trials.

The D2 Group will finish their first European Phase II clinical trial for the treatment of herpes simplex labialis infections (HSV1) by the end of 2011.